Regional Myocardial Remodeling Characteristics Correlates With Cardiac Events in Sarcoidosis

Background: The poor prognosis of cardiac sarcoidosis (CS) underscores the need for risk stratification. Purpose: To investigate the prognostic significance of ventricular/myocardial remodeling features in sarcoidosis. Study Type: Retrospective. Population: In all, 132 biopsy-proven sarcoidosis patients imaged from 2008 to 2018. The primary endpoint was a composite of cardiac mortality, new onset arrhythmias, hospitalization for heart failure, and device implantation. Field Strength/Sequence: No field strength or sequence restrictions. Assessment: Global and regional ventricular/myocardial remodeling features were assessed by standard volumetric measurements and automated function imaging postprocessing analysis. Statistical Tests: Student's t-test or Mann–Whitney test (chi² test or Fisher's exact test for categorical variables) were used for comparisons. Cox-proportional hazards regression model, univariate /multivariate analyses, and receiver operating characteristic were performed to relate clinical/lab data, imaging parameters to the endpoints. Results: Over a median follow-up of 40.7 (interquartile range 18.8–60.5) months, 41 (31.1%) patients developed adverse cardiac events. Abnormal left ventricular (LV) geometric remodeling alterations (measured by LV mass index and relative wall thickness) occurred 3.66-fold more frequently in patients with endpoints than patients without. The ratio of patients with endpoints increased as ventricular remodeling phenotype progressed. In patients with endpoints, regional myocardial wall thickness (RMWT) was significantly (P = 0.022) increased in six clustered LV segments located in the middle interventricular septum and basal/middle anterolateral walls. In all of the abnormal ventricular remodeling stages, patients with endpoints constantly had higher mean RMWT than those without. Among clinical, electrocardiographic, and imaging parameters, LV mass index (hazard ratio [HR] 1.010 95% confidence interval [CI] 1.002–1.018, P = 0.017) and mean RMWT (HR 3.482 95% CI 1.679–7.223, P = 0.001) were independently associated with endpoints. Sarcoidosis patients without this RMWT distribution pattern were significantly (P < 0.001) more likely to be free of the occurrence of subsequent cardiac events. Data Conclusion: Regional myocardial remodeling characteristics are associated with subsequent adverse cardiac events in sarcoidosis. Level of Evidence: 3. Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2020;52:499–509.